FROM MY ANALYSIS THERE IS A CHANCE FOR AUROPHARMA TO TAKE SUPPORT FROM 955 RANGE BECAUSE ITS A PREVIOUS SUPPORT AND ALSO ANALYSING WITH FIBONOCCI RETRACEMENT IT9 955 RANGE IS ABOUT 60% LINE WHICH WILL ACT AS A MAJOR SUPPORT LINE(CONSIDER ONLY STUDY PURPOSES) Tgt1 -1052